ABX PENTRA Creatinine 120 CP, Model Number Creatinine Part # A11A01868, Lot Numbers: 203273706, 2...
FDA Device Recall #Z-0289-2013 — Class III — September 14, 2012
Recall Summary
| Recall Number | Z-0289-2013 |
| Classification | Class III — Low risk |
| Date Initiated | September 14, 2012 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Horiba Instruments, Inc dba Horiba Medical |
| Location | Irvine, CA |
| Product Type | Devices |
| Quantity | 8,503 units |
Product Description
ABX PENTRA Creatinine 120 CP, Model Number Creatinine Part # A11A01868, Lot Numbers: 203273706, 203273707, 203273808, 203273709. The ABX PENTRA Creatinine 120 CP is an in vitro diagnostic assay for the quantitative determination of creatinine in human serum, plasma and urine based on a kinetic method using alkaline picrate (Jaffe method). It is composed of a 27 ml monoreagent cassette. Reagent is a chemical solution with additives. ABX PENTRA Creatinine 120 CP reagent, with associated calibrator and controls, is a diagnostic reagent for quantitative in vitro determination of Creatinine in human serum, plasma and urine based on a kinetic method using alkaline picrate (Jaffe method). Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for measuring other urine analytes. This reagent is intended for use on the ABX PENTRA 400 Clinical Chemistry Analyzer.
Reason for Recall
This recall was initiated because some customers were experiencing an alarm during Creatinine calibration "REAG RANGE HIGH". This alarm caused the calibration to fail and prevented the user from using the Creatinine assay.
Distribution Pattern
Nationwide Distribution
Lot / Code Information
Model Number Creatinine Part # A11A01868, Lot Numbers: 203273706, 203273707, 203273808, 203273709.
Other Recalls from Horiba Instruments, Inc dba Horiba Me...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2286-2018 | Class II | ABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, RE... | Apr 26, 2018 |
| Z-0494-2018 | Class II | 15 ML REAGENT CUP, B1037307, SAP 1221037307 for... | Nov 21, 2017 |
| Z-0493-2018 | Class II | 10 ML REAGENT CUP, B1034626, SAP 1221034626 for... | Nov 21, 2017 |
| Z-0902-2015 | Class II | ABX PENTRA Reagent Container, Model No. B103730... | Nov 13, 2014 |
| Z-2692-2014 | Class II | ABX PENTRA Magnesium RTU Reagent, Part No. A11A... | Aug 11, 2014 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.